AxoSim empowers advancements in human neuroscience and accelerates the drug development process through our drug discovery platforms, NerveSim™ and BrainSim™.
Learn More
Our technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.
Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.
Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.
AxoSim's NerveSim™ Platform, powered by Nerve-on-a-Chip® facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim™ is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
On Tuesday, June 30th, 2020 AxoSim held an interactive webinar: NerveSim™ and BrainSim™: Platforms for Neurological Drug Discovery and Toxicology Screening. Lowry […]
Read MoreOn Tuesday, June 30th, at 12pm EST AxoSim will be hosting a Webinar: NerveSim™ and BrainSim™ Platforms for Neurological Drug Discovery and […]
Read MoreOn Tuesday, June 30th at 12pm EST, join Helena Hogberg, PhD and Lowry Curley, PhD for an interactive webinar to learn more […]
Read MoreMay 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by Nerve-on-a-Chip® Using […]
Read More
